Neuroblastoma (NB), an embryonal malignancy, originates from sympathetic neurons, which are derived from the neural crest. NB represents the most common solid tumor of early childhood. Both metastatic NB in children aged up to 1 year at diagnosis and MYCNamplified NB are high-risk NB (HR-NB) and account for more than 50% of all cases. These HR-NB are very often refractory to conventional dose-intensive therapy.
Indeed, most HR-NB patients present a dramatic prognosis (about 25% overall survival at 5 years) despite intensive high-dose and myeloablative chemotherapy, with a rescue therapy involving autologous hematopoietic stem cell transplantation, followed by a maintenance regimen of 13-cis-retinoic acid (RA) (Matthay et al., 1999; Reynolds et al., 2003) . We are still lacking information on the proteins or genes involved in HR-NB dissemination.
In order to identify metastatic-related genes in NB, we performed a cDNA array analysis of malignant neuroblasts derived from a human NB experimental model (IGR-N-91 model), which had been previously characterized in our laboratory and derived from an HR-NB (Ferrandis et al., 1994) . Briefly, an in vitro NB cell line, IGR-N-91, when injected subcutaneously in nude mice, yielded a primary tumor xenograft (PTX), and metastatic neuroblasts in two sites, myocardium (Myoc) and bone marrow (BM). Then PTX, Myoc, and BM neuroblasts were subcultured to establish the three respective cell sublines. We have reported data showing that this experimental model is appropriate for studying aggressive disease and chemoresistance mechanism in HR-NB (Blanc et al., 2003) . All IGR-N-91-derived neuroblasts harbor a consistently high MYCN amplification but, when compared to PTX, BM and Myoc human neuroblasts elicit a concomitant increase in MYCN and P-gp/MDR1 expressions (Blanc et al., 2003) . Our data showed that the MycN protein activates the transcription of the MDR1 gene and contributes to the drug resistance acquisition, which occurs throughout the HR-NB's metastatic process. Using this model, the analysis of gene expression profiles provided 18 significant differentially expressed genes in metastatic BM and Myoc compared to PTX neuroblasts. The candidate genes listed in Figure 1a include development genes: sonic hedgehog (SHH), disheveled 1 (DVL1), winglesstype 5a (WNT-5A), notch Drosophila homolog of 4 (NOTCH4); signaling genes: interleukin 13 (IL13), basigin (BSG), linker for activation of T cells (LAT); cell adhesion genes: caveolin-1 (CAV1), chondroitin sulfate proteoglycan 1 (CSPG1), cadherin-associated protein-related (CAPR), integrin alpha-8 (ITGA8); and detoxication genes: superoxide dismutase 1 (SOD1), glutathione S-transferase y2 (GST-y2), cell cycle and protein/RNA turnover genes cyclin A2 (CCNA2), cyclin B1 (CCNB1), CDC28-asociated protein CKS1 (CSK1), E2F transcription factor 3 (E2F3), and ribosomal S6 kinase 1 (RSK1). Interestingly, some developmental genes are coordinately downregulated in metastatic neuroblasts (BM and Myoc). These genes belong to the Hedgehog (Shh), Wnt (DVL1 and Wnt-5a) and Notch (Notch 4) signaling pathways, well known for their role during development in orchestrating patterning, organogenesis and cell fate in embryogenic processes, and their recently identified involvement in human cancer (Taipale and Beachy, 2001) . Indeed, when deregulated, many genes may be associated with specific human cancers via key regulator gene alterations. For example, oncogenic mutations have been described for b-catenin and APC in colon carcinoma (Polakis, 2000) , Notch in T-cell leukemia (Ellisen et al., 1991) , and Shh in medulloblastoma (Wechsler-Reya and Scott, 1999) .
The neural crest origin of NB focused our interest on Wnt-5a, a member of the Wnt family, which was identified as downregulated in our IGR-N-91 metastatic model. Quantitative RT-PCR and Western blot analyses confirmed that a significant decrease of Wnt-5a gene expression occurred in BM and Myoc neuroblasts when compared to PTX neuroblasts ( Figure 1b) . Furthermore, Wnt-5a has been shown to be upregulated in many human cancers (Iozzo et al., 1995) as well as in the metastatic dissemination of melanoma (Weeraratna et al., 2002) . In contrast, it has been shown to be downregulated in invasive ductal breast cancer (Jo¨nsson et al., 2002) . No gene amplification or rearrangement of the Wnt-5a gene has been reported in these cancers. We therefore used the results obtained from our IGR-N-91 metastatic model to extend the measurement of Wnt-5a gene expression by QRT-PCR into a set of 37 primary NB tumors. On the basis of clinical and biological criteria, including the MYCN copy number, and the overall survival at 2 years after diagnosis, two main groups of NB tumors were defined as having a favorable (F) or unfavorable (Uf) prognosis (Table 1 ). The first group of 25 patients with an F prognosis encompassed stage 1, 2 and 3 tumors (n ¼ 13) and stage 4o1 year of age tumors (n ¼ 12). The second group, which included 12 HR-NB patients with an Uf prognosis, encompassed stage 4>1 year of age tumors, including MYCNnonamplified (n ¼ 8) and MYCN-amplified patients (n ¼ 4), associated with a dramatic prognosis or a fatal outcome. A significantly reduced Wnt-5a gene expression appears to be correlated with this highly aggressive HR-NB tumor class (Po0.007, Wilcoxon's test) ( Figure 1c ). However, Wnt-5a role in NB metastatic process cannot be now established unless Wnt-5a stable transfectants are performed in NB cell lines followed by related functional assays in nude mice.
It is well established that Wnt members are secreted as glycoproteins, and involved in the proliferation of stem cells and patterning decisions of the nervous system throughout development, including the specification of the neural crest (Ikeya et al., 1997 , Garcia-Castro et al., 2002 . Wnt-5a is a potential tumor suppressor gene as it has been seen in experiments showing that ectopic Wnt5a, when injected into athymic nude mice, prevents and reverses tumorigenesis (Olson et al., 1997) . Wnt-5a is an important regulator of morphogenetic movements during embryonal development (Huguet et al., 1995) and, more specifically, regulates the proliferation of progenitor cells (Yamaguchi et al., 1999) . Recently, Wnt-5a signaling has been implicated in the development of the pituitary gland and, more specifically, in controlling the organ's shape (Cha et al., 2004) . Importantly, Wnt-5a does not appear to signal via the canonical Wnt/bcatenin-dependent signaling pathway but instead stimulates the Wnt/Ca 2 þ pathway via intracellular Ca 2 þ release and the activation of two kinases, CamKII and PKC (Miller et al., 1999; Ku¨hl et al., 2000) . The misregulation of Wnt signaling such as in the Wnt/ b-catenin pathway has been reported in colon carcinomas (Polakis, 2000) , and in lung cancer with the loss of Wnt7a expression (Calvo et al., 2000; Ohira et al., 2003) , while alterations in cell-cell interaction via the Wnt/Ca 2 þ pathway are the main mechanisms involved in epithelial tumors with metastatic disease (Jo¨nsson and Andersson, 2001; Jo¨nsson et al., 2002; Weeraratna et al., 2002) .
To determine the respective and potential role of the Wnt/b-catenin and Wnt/Ca 2 þ pathways in the IGR-N-91 model, we analysed the b-catenin expression status and PKC activity. No change in b-catenin expression was noted between PTX and BM/Myoc metastatic neuroblasts by Western blot analysis (Figure 2a) . Moreover, immunocytochemistry experiments clearly demonstrated that no significant difference was observed in the expression or nuclear translocation of b-catenin between PTX and metastatic neuroblasts (Figure 2b ). PKC activity was determined by Western blot analysis using antibodies probed with phospho-PKC (pan) and a panel of antiphospho-PKC isoforms. The level of PKC-a/b isoform activity in these isoforms did not vary, while the PKC-y isoform level was only decreased in Myoc neuroblasts when compared to PTX neuroblasts (Figure 2a) . Noteworthy, the PKC-y isoform has been Tissue samples were collected from primary tumors of children as described previously (Douc-Rasy et al., 2002) , and cut into 70-mmthick slices with a cryostat. Hematoxylin-eosin-stained tissue (5 mm) flanking both slides of the thick tumor slices were controlled histologically to determine the percentage of tumor cells: only tumor tissues presenting more than 60% of tumor cells were included in the study. Staging was performed according to the histological criteria. PCR amplification of MYCN copy number was performed using a TaqMan 5 0 nuclease fluorigenic real-time quantitative PCR assay with the ABI PRISM 7700 Sequence Detection System (PE Biosystems). Primers have been described previously (Blanc et al., 2003) . Overall 2-year survival of patients was about 90% for the favorable (F) group compared to 58% for the unfavorable (Uf) group Wnt-5a expression in neuroblastoma E Blanc et al
shown to be involved in several functions such as cell cycle progression (Datta et al., 1997) , reorganization of the actin skeleton (Tang et al., 1997) and T-cell activation (Monks et al., 1997) . PKC-y expression has also been demonstrated in cells of neural origin such as microglial and astroglial cells (Slepko et al., 1999) and the LAN-5 NB (Passalacqua et al., 1999) . The development of the neural crest and sympathetic nervous system depends on various factors such as FGFs and RA signals (Christiansen et al., 2000) . During embryogenesis, RA induces neuroectodermal differen- Figure 1 (a) Representative differential gene expression in metastatic NB cell lines, defined by a twofold or greater change relative to the expression in the PTX cell line. The IGR-N-91 cell line was established from an involved BM harvested from a highrisk NB (stage 4-NB, 8-year-old boy). Neuroblasts were injected subcutaneously into nude mice and a PTX was isolated while metastatic neuroblasts were isolated from the Myoc and BM. These neuroblasts were further cultured in vitro on bovine corneal extracellular matrix to establish sublines. These IGR/PTX, IGR/ Myoc and IGR/BM sublines were maintained as reported earlier (Blanc et al., 2003) . The exponentially growing IGR/PTX, IGR/ BM and IGR/Myoc neuroblasts were grown to about 80% confluency and then harvested for RNA extraction. Gene expression analyses were performed by hybridizing labeled cDNA from human cell lines onto the Atlast Human Cancer 1.2 arrays (Clontech Laboratories, Ozyme, France). Total RNA (2 mg) was reversed transcribed and labeled using [a-32 P]dATP. The probe was then hybridized on cDNA spotted arrays. Hybridization was performed at 601C with continuous agitation overnight. The printed surface of membranes was exposed to a PhosphorImager screen for 24 h, and then scanned at a resolution of 50 mm. Analysis was performed using the AtlasImage 2.01 software (Clontech). Global normalization using the sum method was used to compare the membranes. For positive controls, we used the following housekeeping genes: b-actin, ubiquitin, and GAPDH (among others). Experiments were performed twice. PubMed Accession numbers are:
Analysis of Wnt-5a gene expression in NB cell lines. The RNAs (1 mg) were subjected to realtime RT-PCR analyses using the TaqMan procedure described previously (Blanc et al., 2003) . The primers were determined as follows: cWnt-5a forward primer, 5 0 -GCC AAG GGC TCC TAC GAG AG-3 0 ; cWnt-5a reverse primer, 5 0 -AGC CAG GTT GTA CAC CGT CC-3 0 ; and the TaqMan probe, FAM5 0 -AAC CTG CAC AAC AAC GAG GCC G-3 0 TAMRA. Ct values (fractional cycle number at which the fluorescence generated by cleavage of the probe crosses a fixed threshold) were determined. Calibration curves plotting Ct against reference cDNA quantity were generated and cDNA level for the test sample was determined by extrapolation. Control parental IGR-N-91 cells were used. Samples were normalized using 18S mRNA expression with primers described previously (Blanc et al., 2003) . Duplicates were used in each individual experiment and results are the mean of three independent experiments7s.d. The difference of Wnt-5a gene expression level is significant between PTX and BM/Myoc neuroblasts and noted (**Po0.01) according to an unpaired Student's t-test. Controls have been performed without reverse transcriptase and are negative for every sample (data not shown). (c) Wnt-5a is decreased in unfavorable neuroblastic tumors. Levels of Wnt-5a gene expression in favorable (F) versus unfavorable (Uf) neuroblastic tumors were performed by QRT-PCR analysis as described above. A significantly reduced Wnt-5a level is noted in the Uf group compared to the F group according to Wilcoxon's test (Po0.007) Wnt-5a expression in neuroblastoma E Blanc et al tiation with the formation of several cell types, including neurons, glia, and fibroblast-like cells. In undifferentiated human embryonal carcinomas, which do not express Wnt genes, it has been shown that Wnt expression occurs upon RA-induced differentiation (Katoh et al, 1996) and, more specifically, involves a developmental regulation of the human Wnt-13 (Wakeman et al., 1998). Moreover, the expression of multiple Wnt signaling molecules changed during the early phase of neuronal differentiation by RA (Katoh, 2002) . Thus, in order to determine if RA might reverse the aberrant negative regulation of Wnt-5a in metastatic neuroblasts, we investigated Wnt-5a gene expression in RA-differentiated neuroblasts of the IGR-N-91 model including PTX, BM and Myoc cell sublines. Following treatment with 10 mM RA for 6 days, PTX, BM and Myoc neuroblasts underwent neuronal differentiation as assessed from neuritic extensions (Figure 3a ) and the increase of GAP43 gene expression in PTX neuroblasts (Figure 3b) . The growth-associated protein 43 (GAP43) is a neuronal protein with an important role in cytoskeleton-associated processes involved in the extension and sprouting of nerve growth cones (Aigner et al., 1995) . No variation of GAP43 gene expression was noted in BM and Myoc metastatic neuroblasts. Indeed, GAP43 is a recognized marker of terminal neuronal differentiation and its expression is probably delayed in metastatic neuroblasts. Furthermore, we observed a marked reduction in MYCN expression both at the mRNA and protein levels (Figure 3c and d) . Of note, the MYCN decrease is a specific event, which has been previously described in RA-differentiated neuroblasts (Thiele et al., 1985) . QRT-PCR and immunocytochemistry showed a significant increase in Wnt-5a gene expression (Figure 3e and f) . This paralleled the increase in PKC-y levels in RA-differentiated neuroblasts, while b-catenin levels and localization remained unchanged (Figure 3g and h) . Importantly, it has been evidenced that PKC-y plays a specific role in the neuronal cells differentiation program and, for example, is upregulated in RA-treated PC12 and human NB cells (Sparatore et al., 2000a, b) .
In order to determine whether Wnt-5a alone was able to change the morphology of neuroblasts, Wnt-5a was overexpressed in PTX neuroblasts following a transient transfection with a Wnt-5a plasmid vector for 48 h. Neither neuritic outgrowth nor reduced MycN levels were noted in Wnt-5a-transfected PTX (Figure 4a , lane 4), while RA induced a reduced level of MycN and a significant expression of Wnt-5a (lane 6). To further investigate whether MycN and Wnt-5a act independently, we studied the effect of 10 mM RA treatment on the MYCN-nonamplified SH-SY5Y human NB cell line, a well-established system for studying neuronal differentiation (Ko¨rner et al., 1995; Pahlman et al., 1995) . Indeed, it has been shown that RA rapidly drives the the Wnt-5a and PKC-y gene expressions were concomitantly increased, while b-catenin levels were found to be unchanged (Figure 4c and d) . Thus, simultaneous variations of Wnt-5a and PKC-y may occur in response to RA in malignant neuroblasts ) were seeded into 25 cm 2 tissue culture flasks in 5 ml of culture medium for 24 h. The medium was then replaced with a fresh medium containing 10 mM RA or the vehicle DMSO. Cells were harvested 6 days later. The fresh growth medium and agents were replenished after 2 days. RA (all-trans-RA) was purchased from Sigma (St Louis, MO, USA) and stored as a 100 mM stock solution dissolved in DMSO. (b) Expression of GAP 43 mRNA in neuroblasts after 10 mM RA induction for 6 days. RT-PCR was performed using primers as described previously (Rague´nez et al., 1999) . (c) A significantly reduced MYCN gene expression is observed by QRT-PCR (***Po0.001) and (d) by Western blot in RA-differentiated neuroblasts. (e) A significant increase of Wnt-5a gene expression is noted by QRT-PCR in RA-differentiated neuroblasts (***Po0.001). (f) Immunofluorescence pictures showing a Wnt-5a high expression in RA-differentiated PTX neuroblasts. Cells were fixed for 30 min at 41C in paraformaldehyde 1%, rinsed three times in PBS, and then incubated for 1 h with the Wnt-5a primary antibody diluted at 1 : 20. The panels show cells stained with propidium iodide (PI) and Wnt-5a antibody. (g) Western blots of b-catenin and phospho-PKC-y proteins in RA-differentiated neuroblasts. (h) The analysis of PKC-y mRNA was also performed by RT-PCR using the following primers: c PKC-y forward primer, 5 0 -GCA GGA TCC CCA TGT CGC CAT TTC TTC G-3 0 ; c PKC-y reverse primer, 5 0 -GCT GTC GAC CAG GAA ATG CCC TGA GGC TC-3 0 (Zeidman et al., 1999) Wnt-5a expression in neuroblastoma E Blanc et al regardless of whether they express MYCN or not. To sum up, this is the first time that the involvement of Wnt-5a, an actor in embryonic and morphogenetic processes, has been described in the pathogenesis of a pediatric embryonal malignancy. Moreover, RA-induced neural differentiation is independent of the level of MYCN amplification and is concomitantly associated with increased Wnt-5a and PKC-y gene expressions. Whether Wnt-5a promoter harbors RA-responsive elements still remains to be elucidated. The malignant neuroblast RA response is consistent with clinical studies showing that retinoid therapy is effective against residual metastatic NB disease and improves the event-free survival in high-risk NB (Reynolds et al., 2003) . Further investigations are required to determine whether Wnt-5a gene upregulation might reflect the ability of malignant neuroblasts to respond to RA.
